Soros Fund Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-700,000
Closed -$13.7M 250
2024
Q4
$13.7M Sell
700,000
-50,000
-7% -$991K 0.21% 105
2024
Q3
$13.7M Buy
750,000
+150,000
+25% +$2.86M 0.2% 103
2024
Q2
$10.4M Buy
600,000
+375,000
+167% +$6.64M 0.19% 112
2024
Q1
$4.41M Buy
225,000
+25,000
+13% +$528K 0.07% 151
2023
Q4
$4.61M Buy
200,000
+60,000
+43% +$1.34M 0.06% 168
2023
Q3
$3.22M Buy
+140,000
New +$3.56M 0.05% 178

Other funds holding PRVA

Soros Fund Management's PRVA Position: Q1 2025 in Review

Soros Fund Management sold out of Privia Health (PRVA) in Q1 2025, closing a stake of 700,000 shares — an estimated $13.7M sold.

Soros Fund Management first reported a position in PRVA in Q3 2023 and held it in 6 quarters. The position peaked at $13.7M in Q4 2024. 248 funds tracked by Wall St. Rank hold PRVA as of Q1 2025.

  • Soros Fund Management reported no remaining Privia Health position as of Q1 2025 after selling out during the quarter.
  • Soros Fund Management sold 700,000 Privia Health shares in Q1 2025, an estimated $13.7M.
  • Soros Fund Management first reported a position in Privia Health in Q3 2023 and held it in 6 quarters.
  • Soros Fund Management's Privia Health position peaked at $13.7M in Q4 2024.
  • 248 funds tracked by Wall St. Rank held Privia Health as of Q1 2025.

Based on Soros Fund Management's 13F filing for Q1 2025, filed 15 May 2025.